392 related articles for article (PubMed ID: 17081566)
1. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
[TBL] [Abstract][Full Text] [Related]
2. Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.
Shinoda M; Tilles AW; Wakabayashi G; Takayanagi A; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
Tissue Eng; 2006 May; 12(5):1313-23. PubMed ID: 16771644
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure.
Shito M; Tilles AW; Tompkins RG; Yarmush ML; Toner M
J Surg Res; 2003 May; 111(1):53-62. PubMed ID: 12842448
[TBL] [Abstract][Full Text] [Related]
4. Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure.
Zheng YB; Zhang XH; Huang ZL; Lin CS; Lai J; Gu YR; Lin BL; Xie DY; Xie SB; Peng L; Gao ZL
PLoS One; 2012; 7(7):e41392. PubMed ID: 22844472
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of co-microencapsulated hepatocytes and HUVECs for treatment of fulminant hepatic failure.
Qiu L; Wang J; Wen X; Wang H; Wang Y; Lin Q; Du Z; Duan C; Wang C; Wang C
Int J Artif Organs; 2012 Jun; 35(6):458-65. PubMed ID: 22562371
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin increases survival and attenuates fulminant hepatic failure injury induced by D-galactosamine/lipopolysaccharide in mice.
Ben-Ari Z; Zilbermints V; Pappo O; Avlas O; Sharon E; Greif F; Cheporko Y; Ravid A; Shapiro R; Hochhauser E
Transplantation; 2011 Jul; 92(1):18-24. PubMed ID: 21516061
[TBL] [Abstract][Full Text] [Related]
8. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
[TBL] [Abstract][Full Text] [Related]
9. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
[TBL] [Abstract][Full Text] [Related]
10. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
11. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
Chen EQ; Gong DY; Leng XH; Bai L; Liu C; Wang LC; Tang H
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):624-9. PubMed ID: 23232634
[TBL] [Abstract][Full Text] [Related]
13. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of the pretreatment and treatment with RhIL-11 on acute liver failure induced by D-galactosamine.
Nie XH; Han T; Ha FU; Liang N; Wang SH; Zhu ZY; Xiang HL
Eur Rev Med Pharmacol Sci; 2014; 18(8):1142-50. PubMed ID: 24817287
[TBL] [Abstract][Full Text] [Related]
15. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of neutrophil elastase inhibitor (FR136706) in lethal acute liver failure induced by D-galactosamine and lipopolysaccharide in rats.
Uchida Y; Kaibori M; Hijikawa T; Ishizaki M; Ozaki T; Tanaka H; Matsui K; Tokuhara K; Kwon AH; Kamiyama Y; Okumura T
J Surg Res; 2008 Mar; 145(1):57-65. PubMed ID: 17936791
[TBL] [Abstract][Full Text] [Related]
17. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure.
Chen L; Xiang B; Wang X; Xiang C
Stem Cell Res Ther; 2017 Jan; 8(1):9. PubMed ID: 28115012
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expressions and activations of leukotriene C4 synthesis enzymes in D-galactosamine/lipopolysaccharide-induced rat fulminant hepatic failure model.
Ma KF; Yang HY; Chen Z; Qi LY; Zhu DY; Lou YJ
World J Gastroenterol; 2008 May; 14(17):2748-56. PubMed ID: 18461660
[TBL] [Abstract][Full Text] [Related]
20. Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity.
Regmi S; Pathak S; Thanh TP; Nguyen TT; Sung JH; Yook S; Kim JO; Yong CS; Choi I; Doh KO; Park PH; Park JB; Seo Y; Kim BK; Lee DM; Moon IJ; Kim HS; Jeong JH
Stem Cell Res Ther; 2019 Oct; 10(1):230. PubMed ID: 31615539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
